Gerresheimer invests in plastics with two new plants
Gerresheimer is increasing its presence in the pharmaceutical plastics business, which it believes is increasingly important, by opening an R&D centre in the US and a production facility in Spain.
Archives for September 21, 2009
Synthetic PEG could cut interferon dosing requirements
Coupling interferon to a synthetic PEG molecule could increase the therapeutic’s dosing schedule from every other day to every one to two weeks, according to researchers who believe the technology has blockbuster potential.
Appointments at IMS Health, CPTC and LAB Research Canada – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing space, including appointments at IMS Health, CPTC and LAB Research Canada.
B-MS calls on Advogent for logistics and sales support
New Jersey-based communications group Advogent has had its sales logistics contract renewed by US drugmaker Bristol-Myers Squibb (B-MS).
Dalton adds formulation service to manufacturing offering
Dalton Pharma Services has rolled out a new formulation development service that completes the firm’s contract drug manufacturing offering according to CEO Peter Pekos.
TriLink restarts radiolabelling service
San Diego’s TriLink BioTechnologies has restarted its contract oligonuclotide radio-labelling service after receiving “anxious phone calls” from pharma customers, according to CEO Richard Hogrefe.
Sentinel Initiative will help with postmarketing objectives; PRA
The Sentinel Initiative will help pharma and CROs pinpoint study objectives, according to a director at PRA who told Outsourcing-Pharma about the company’s postmarketing safety surveillance.